Boards & Committees - Annual Meeting


The Symposia Planning Committee members have been selected to represent the following categories:



Meeting Webpage

Symposia Planning Meeting: July 20-21, 2013, Philadelphia, PA, USA

Abstract Selection Meeting and Conference Calls: December 16-17, 2013, Washington, DC

  • The Annual Meeting Scientific Program Committee shall consist of a Vice-Chair appointed by the President-Elect and a Chair who shall rotate into the position after serving as Vice-Chair. Chair and Vice-Chair terms are one year each.
  • The Chair shall appoint sufficient additional committee members to reflect the disciplines of the abstract categories and to ensure, to the extent possible, representation from among the various geographic and specialty constituencies of the Society. Such terms are for one year.
  • The Immediate Past Chair, the Editor of the Journal, the President, and the Chair of the Development Committee shall also serve as members of the Program Committee.
  • If not already an elected Board member, the Chair of the Annual Meeting Scientific Program Committee shall serve as an ex-officio member of the Board of Directors and shall also serve as a member of the Education Committee.

  1. Develop learning objectives for the Annual Meeting that are tied to the identified educational needs of the members.
  2. Ensure that the Annual Meeting Scientific Program meets the identified educational needs of the members and the established learning objectives.
  3. Develop the Annual Meeting Scientific Program content, including the selection of abstract presentations and the development and selection of symposia.
  4. Make revisions to the scientific program to ensure it continues to meet the educational needs of the members.
  5. Evaluate and make changes, as needed, to the format, structure, and content development process of the Annual Meeting Scientific Program
Jason D. Christie, MD, MS
University of Pennsylvania
Philadelphia, Pennsylvania, USA

Jason Christie, MD, MS, is the Section Chief of Medical Critical Care at the University of Pennsylvania Perelman School of Medicine. He is currently Associate Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania. He is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics, and the Director of Clinical Research in the Pulmonary Division. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury (ALI) in the transplant and non-transplant human populations..

Allan R. Glanville, MD, FRACP
St. Vincent's Hospital

Professor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.

Andreas Zuckermann, MD,
Medical University of Vienna

Bio coming soon...

COMMITTEE MEMBERS (in alphabetical order by CATEGORY)
John A. Belperio, MD
UCLA Pulmonary & Critical Care Medicine
Los Angeles, California, USA

Bio coming soon...

Esmé Dijke, PhD
University of Alberta
Edmonton, Alberta, CANADA

Esmé Dijke works as a Post-doctoral Fellow at the University of Alberta in Edmonton under the supervision of Dr. Lori West. She graduated cum laude from the Rotterdam University in Rotterdam (Netherlands) with a Bachelor of Applied Sciences degree in Biotechnology. She received her PhD in the laboratory of Dr. Carla Baan and Dr. Willem Weimar at the Erasmus University in Rotterdam, where her doctoral studies focused on the role of regulatory T cells in adult heart transplant recipients. Her research interests are the role of regulatory T cells and B-cell memory in infants and its possible relation to development of tolerance to graft antigens.

Daniel C. Chambers, MBBS, MD
The Prince Charles Hospital
Brisbane, Queensland, AUSTRALIA

Dan Chambers, MBBS MRCP FRACP MD, is a Thoracic and Transplant Physician and Head of Research in the Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Australia. He is also Associate Professor in the School of Medicine, University of Queensland, and Deputy Chair of the Metropolitan North Human Research and Ethics Committee. He is a member of the Lung Standing Committee for the Transplantation Society of Australia and New Zealand, and the Research Subcommittee for the Thoracic Society of Australia and New Zealand. His main research interests include the pathogenesis of chronic lung allograft dysfunction, early detection of lymphocytic bronchiolitis, lung metagenomics, adult lung disease complicating extreme preterm birth and cell therapy for advanced lung disease.

Lori J. West, MD, DPhil
University of Alberta
Edmonton, Alberta, CANADA

Dr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.
Marisa Crespo-Leiro, MD
Hospital Universitario A Coruña
La Coruña, SPAIN

Maria G (Marisa) Crespo-Leiro, MD, PhD, FESC, is the Medical Director of the Advanced Heart Failure Transplant Unit at the Hospital Universitario A Coruña, La Coruña, Spain.  She obtained her MD degree at the University of Santiago de Compostela, her specialization in cardiology at Clinica Puerta de Hierro in Madrid and her PhD from Universidad Autónoma de Madrid. Since 1993 she has been working in the Heart Division at the Hospital Universitario A Coruña (formerly the Hospital Universitario Juan Canalejo) in La Coruña, where she is also Associate Professor of Medicine. Her main fields of research interest are heart failure and heart transplantation.

Goran Dellgren, MD
Sahlgrenska University Hospital
Goteborg, SWEDEN

Dr. Goran Dellgren is a cardiothoracic surgeon and Director of Heart and Lung Transplantation at the Sahlgrenska University Hospital, in Gothenburg, Sweden. He finished medical school 1989 at Karolinska Institute, Stockholm, Sweden and after an Internship at Örebro Hospital he became a resident at Dept. Cardiothoracic Surgery at Karolinska University Hospital 1992. When board certified in cardiothoracic surgery he became Staff Surgeon at Huddinge Univ Hospital 1997. 1998 he started as a clinical and research fellow at the Dept. Cardiac Surgery, Toronto General Hospital, which was followed 1999 by another year at the Dept. Pediatric Cardiac Surgery, The Hospital for Sick Children, Univ of Toronto. After returning to Huddinge Univ. Hospital, Stockholm in 2000 he finished his PhD thesis 2002 and became consultant. In 2008 Dr. Dellgren became Director of Heart and Lung Transplantation, Transplant Institute and Dept. Cardiothoracic Surgery at The Sahlgrenska Univ. Hospital in Gothenburg, Sweden. He has an ongoing interest in clinical, epidemiological and experimental heart and lung transplantation.

Howard J. Eisen, MD, FAHA, FACC, FACP
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA

Dr. Eisen obtained his MD from the University of Pennsylvania (UPenn) School of Medicine in 1981 where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at the Hospital of UPenn (1981-1984), followed by a fellowship in cardiovascular medicine at Washington Univ in St. Louis and Barnes Hospital (1984-87) where he received training in the management of cardiac transplant recipients. He subsequently was on the faculty of UPenn School of Medicine and Temple Univ before joining the Drexel Univ College of Medicine and Hahnemann Univ Hospital as Chief of the Division of Cardiology in 2005. Dr. Eisen has been funded by the NIH to study microchimerism and cell adhesion molecule expression in cardiac transplant rejection and has played an important role in the investigation of gene expression profiling in cardiac transplantation. Dr. Eisen is board certified in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine.

David S. Feldman, MD, PhD
Minneapolis Heart Institute
Minneapolis, Minnesota, USA

Bio coming soon...

Ashish S. Shah, MD
Johns Hopkins Hospital
Baltimore, Maryland, USA

Bio coming soon...

Michal Zakliczynski, MD
Slaskie Centrum Chorb Serca
Zabrze, POLAND

Bio coming soon...
Stanley I. Martin, MD
Ohio State University Medical Center
Columbus, Ohio, USA

Stanley Martin, MD, is an Assistant Professor in the Division of Internal Medicine at The Ohio State University Medical Center. Dr. Martin has a clinical and research interest in infectious diseases related to non-HIV immunocompromised hosts. His work and training have focused mainly on patients undergoing solid organ and bone marrow transplantation. His research interests have included molecular virology in transplantation, xenotransplantation, and infectious complications of monoclonal antibody therapy. Dr. Martin earned his MD at the University of Tennessee and subsequently completed his internship and residency in Internal Medicine at the Mayo Clinic in Rochester, MN. He went on to complete an infectious diseases fellowship at Massachusetts General Hospital in Boston, MA.

Amparo Sole, MD, PhD
University Hospital la Fe Valencia
Valencia, SPAIN

Amparo Sole, MD, PhD, is a pulmonologist professor of lung transplant medicine at EVESP (Escuela valenciana de estudios superiores). She is Director of the Adult Cystic Fibrosis Unit and Senior Consultant of the Lung Transplant Unit at the University and Polytechnic Hospital La Fe in Valencia, Spain. Her clinical interests include lung transplant, heart-lung transplant, transplant outcomes, and cystic fibrosis. She has developed her career in the field of  lung transplant at several hospitals around the world, being a visitor and researcher at the Royal Brompton Hospital of London, Freeman Hospital in Newcastle (England), Toronto General Hospital in Ontario (Canada), and at St. Vincent's Hospital in Sydney (Australia). She was president of the 33rd European Cystic Fibrosis Conference held in Valencia in June, 2010. Currently she is the President of the Spanish Scientific Society of Cystic Fibrosis.
Tobias Deuse, MD, PhD
University Heart Center Hamburg
Hamburg, GERMANY

Bio coming soon...

Allan R. Glanville, MD, FRACP
St. Vincent's Hospital

See bio above under "President and Past Program Chair"

Denis Hadjiliadis, MD
University of Pennsylvania
Philadelphia, Pennsylvania, USA

Dr Hadjiliadis is the Paul F Harron Jr Associate Professor of Medicine and the Director of the Adult Cystic Fibrosis Program at the University of Pennsylvania and a member of the Lung Transplant Program at the University of Pennsylvania. He is also the physician leader of the Advanced Lung Disease Research Group. Dr Hadjiliadis completed his medical degree at the University of Toronto, his Internal Medicine residency at the Mayo Clinic and his Pulmonary and Critical Care fellowship at Duke University Medical Center. He subsequently completed an advanced fellowship in Lung Transplantation and Cystic Fibrosis at the University of Toronto and joined its faculty prior to coming to the University of Pennsylvania. His main interests include patient selection and outcomes in lung transplantation, clinical trials in cystic fibrosis and prediction of outcomes and complications in cystic fibrosis. He is board certified by ABIM in Internal Medicine, Pulmonary Disease and Critical Care and by the Royal College of Physicians and Surgeons of Canada in Internal medicine and Respirology.

David Lederer, MD, MS
Columbia University Medical Center
New York, NY, USA

Bio coming soon...

Christopher H. Wigfield, MD FRCS(C/Th)
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA

Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at The University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.

Martin R. Zamora, MD
Colorado University Health Science Center
Aurora, Colorado, USA

Bio coming soon...
Emma J. Birks, MBBS, PhD, BSc, FRCP
University of Louisville
Louisville, Kentucky, USA

Emma Birks, MBBS, PhD, FRCP, is the Medical Director of the Jewish Hospital Heart Failure, Transplantation and Mechanical Circulatory Support program and Professor of Cardiovascular Medicine with the University of Louisville. Dr. Birks received her medical training, including her residency and fellowship, at the Royal Free Hospital School of Medicine / University of London.

Jennifer Ann Cowger, MD, MS
St. Vincent Heart Center
Indianapolis, Indiana, USA

Jennifer Cowger, MD, MS, is a clinical lecturer in Cardiovascular Medicine. Her expertise is in advanced heart failure, cardiac transplant, and mechanical support of the heart. Dr. Cowger received her medical degree from the Ohio State University, graduating class valedictorian in 2001. She completed her Internal Medicine Residency at Duke University Medical Center in Durham, North Carolina in 2004. She received her Cardiovascular Medicine Fellowship training at the University of Michigan with subspecialty training in Heart Failure and Cardiac Transplant which was completed in 2007. After concluding her medical education, Dr. Cowger obtained a Masters in Clinical Research and Statistics at the University's School of Public Health. Dr. Cowger's research interests are in mechanical circulatory support of the heart using left ventricular assist devices (LVADs). Her specific research area of focus is on imporving patient outcomes with long term LVAD support. She is also interested in investigating novel means of reducing oxidative stress in the setting of heart failure.

Josef Stehlik, MD, PhD
University of Utah
Salt Lake City, UT, USA

Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.

Martin Strueber, MD
University Heart Center Leipzig
Leipzig, GERMANY
49-341865 1319 / 1421

Bio coming soon...

Marian Zembala, MD, PhD
Silesian University Center Heart Disease
Tarnowskie Góry, POLAND

Bio coming soon...

Andreas Zuckermann, MD,
Medical University of Vienna

Bio coming soon...
Samantha J. Anthony, PhD, MSW
Hospital for Sick Children
Toronto, Ontario, CANADA

Bio coming soon...

Kevin Carney, RN, CCTC
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, USA

Bio coming soon...
Gerald J. Berry, MD
Stanford University
Stanford, California, USA

Bio coming soon...
Christian Benden, MD
University Hospital Zurich
Zurich, Switzerland

Dr. Christian Benden is the Medical Director of Lung Transplantation at the University Hospital Zurich and a Reader in Pulmonology and Transplant Medicine at the University of Zurich, Switzerland. Dr. Benden completed his pediatric training in Hannover (Germany) and London (United Kingdom). In addition, he trained in Pediatric Pulmonology and received specialist training in lung transplantation in London and Zurich. Dr. Benden is a well-recognized Pediatric Lung Transplant Physician, and a former Chair of the ISHLT Scientific Council on Pediatric Transplantation. His research interests include clinical aspects of lung transplantation, particularly in children and adolescents, experimental aspects of chronic lung allograft dysfunction, and cystic fibrosis lung disease.

Tajinder P. Singh, MD
Children's Hospital of Boston
Boston, Massachusetts, USA

Dr. Singh joined Boston Children’s  Hospital’s Cardiovascular and Heart Transplant Program in 2005. He was previously medical director of the Heart Transplant Program at Children's Hospital of Michigan from 1998-2005. He is a clinical researcher with interest in (1) outcomes in children with heart failure and transplant, and (2) cardiovascular physiology (exercise physiology, cardiac innervation, vascular physiology, myocardial metabolism) in children with congenital and acquired heart disease. He has published several studies describing risk factors of mortality in children while waiting and after transplant.  Dr. Singh holds an academic appointment as Assistant Professor at Harvard Medical School.

Tamara E. Claridge, PharmD
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, USA

Bio coming soon...

Walter Uber, PharmD
Medical University of South Carolina
Charleston, South Carolina, USA

Bio coming soon...
Prof Paul A. Corris
Freeman Hospital
Newcastle University & CT Centre
Newcastle Upon Tyne, UNITED KINGDOM

Bio coming soon...

Marc de Perrot, MD, MSc
Toronto General Hospital
Toronto, Ontario, CANADA

Bio coming soon....

Mandeep R. Mehra, MD, MBBS, FACC, FACP
Brigham & Women's Hospital
Boston, MA, USA

Dr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.

Myung H. Park, MD
University of Maryland School of Medicine
Baltimore, MD, USA

Myung Park, MD, FACC, is Director of the Pulmonary Vascular Diseases Program & CCU, and Associate Professor of Medicine, at the University of Maryland Medical Center. After receiving her medical degree from the Temple University School of Medicine, Dr. Park continued her training in Philadelphia with an internship and residency in internal medicine at Temple University Hospital.This was followed by a fellowship in cardiovascular medicine at the Medical College of Virginia. She furthered her training by completing an advanced fellowship in Heart Failure and Cardiac Transplantation at the Cleveland Clinic Foundation. Dr. Park is board certified in cardiology and internal medicine. She specializes in pulmonary hypertension, heart transplantation, advanced heart failure, and ventricular assist devices.

Fernando Torres, MD
UT Southwestern Medical Center
Dallas, Texas, USA

Bio coming soon...

Text SizeIncrease Font SizeDecrease Font Size